Holdings in Company

Summary by AI BETAClose X

Pentwater Capital Management LP has notified Ondine Biomedical Inc. of a change in its major holdings, triggered by an event changing the breakdown of shares outstanding. As of February 27, 2026, Pentwater Capital Management LP's total holding, primarily through financial instruments with similar economic effect such as a swap settled in cash, stands at 3.993187% of the shares outstanding, representing 20,746,666 shares. This marks a slight decrease from their previous notification where their holding was 4.002313%.

Disclaimer*

UK 100

Latest directors dealings